0.6(top 50%)
impact factor
10.5K(top 2%)
papers
35.2K(top 10%)
citations
59(top 10%)
h-index
0.6(top 50%)
extended IF
16.5K
all documents
39.0K
doc citations
81(top 10%)
g-index
Clinical Lymphoma, Myeloma and Leukemia - The graph shows the changes in the impact factor of ^ and its corresponding percentile for the sake
Download data:JSONCSV
Clinical Lymphoma, Myeloma and Leukemia - if-computation
This graph shows how the impact factor of Clinical Lymphoma, Myeloma and Leukemia is computed. The left axis depicts the number of papers published in years X-1 and X-2, and the right axis displays their citations in year X.
Download data:JSONCSV

What is the 2024 impact factor of Clinical Lymphoma, Myeloma and Leukemia?

The 2024 impact factor of Clinical Lymphoma, Myeloma and Leukemia is 0.396. This impact factor has been calculated by dividing the number of citations in the year 2023 to the articles published in 2021 and 2022. Clinical Lymphoma, Myeloma and Leukemia published 1,111 and 1,105 articles in the years 2022 and 2023, which have received 462 and 416 citations in 2024, respectively.